Matthew Lang
2017
In 2017, Matthew Lang earned a total compensation of $2.9M as General Counsel at Myovant Sciences Ltd..
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $131,000 |
| Option Awards | $2,346,492 |
| Salary | $264,193 |
| Other | $68,108 |
| Total | $2,909,793 |
Lang received $2.3M in option awards, accounting for 81% of the total pay in 2017.
Lang also received $100K in bonus, $131K in non-equity incentive plan, $264.2K in salary and $68.1K in other compensation.
Rankings
In 2017, Matthew Lang's compensation ranked 3,752nd out of 14,666 executives tracked by ExecPay. In other words, Lang earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,752 out of 14,666 | 74th |
Division Manufacturing | 1,305 out of 5,770 | 77th |
Major group Chemicals And Allied Products | 364 out of 2,074 | 82nd |
Industry group Drugs | 280 out of 1,730 | 84th |
Industry Pharmaceutical Preparations | 221 out of 1,329 | 83rd |
Source: SEC filing on July 25, 2018.
Lang's colleagues
We found two more compensation records of executives who worked with Matthew Lang at Myovant Sciences Ltd. in 2017.